Search

everythinglearnresearchcommunity

for

Search:↓

A chemical called 5-Bromo-2′-deoxyuridine caused rapid hair loss in mice by killing certain skin cells through a specific cell death pathway.

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

Certain genes control the color of human hair by affecting pigment production.

The conclusion is to use scalp cooling, gentle hair care, and treatments like minoxidil for managing hair loss from chemotherapy, and stresses the need for more research and collaboration in this area.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Alfredo Rebora suggested a new, easier way to classify hair loss in Telogen Effluvium, adding a type possibly related to autoimmune diseases.

Low-dose oral minoxidil effectively treats non-scarring hair loss with some side effects like hypertrichosis and postural hypotension.

Minoxidil tretinoin liposomal based hydrogel shows promise for effective treatment of hair loss by delivering both drugs at the same time.

Pregnancy right after giving birth in mice lacking IL-10 causes milk that leads to liver issues and hair loss in their babies.

Black seed oil significantly protects against hair loss from chemotherapy.

Prenatally androgenized ewes can model increased hair diameter in women with PCOS.

The document concludes that better targeted treatments are needed for wound healing, and single-cell technologies may improve cell-based therapies.

The document concludes that while significant progress has been made in understanding skin biology and stem cells, more research is needed to fully understand their interactions with their environment.

New insights into cell communication in psoriasis suggest innovative drug treatments.

Using minoxidil with laser therapy is more effective for female hair loss than minoxidil alone.

New understanding and treatments for hair loss are improving, but more research is needed.

New methods to improve the healing abilities of mesenchymal stem cells for disease treatment are promising but need more research.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

BMAL1 controls skin cell growth and UV damage risk, peaking at night.

Certain mouse strains develop a skin condition similar to a human hair loss disease due to genetic defects.

Disabling the FGF5 gene in sheep leads to longer wool.

Changes in KRT17 gene activity linked to wool production in Angora rabbits.

Targeting CXXC5 and GSK-3β may help treat male pattern baldness.

Horse skin diseases are complex to manage and often require a biopsy for accurate diagnosis and treatment.

Most minoxidil products on Amazon don't provide safety or side effect information.

Nail loss may be a side effect of the MS drug teriflunomide.

The circadian clock is crucial for tissue renewal and regeneration, affecting stem cell functions and having implications for health and disease.

Proper control of β-catenin activity is crucial for development and preventing diseases like cancer.

The document concludes that sex hormones are crucial for mammalian reproduction, health, and behavior, and require more research for therapeutic use.